Quick Take: The new space will be dedicated to the following services: Bioanalytical testing, Bioassay and in-vitro studies, Research & development and formulation studies for several psychedelic compounds, including ketamine and LSD, and, Small batch manufacturing. Numinus Wellness Inc. (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce the expansion of its psychedelics…